Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSCs Injections for Liver Cirrhosis
NCT04088058Phase 2Unknown
- Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Apr 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of GXHPC1 in Liver cirrhosis (LC), sponsored by Gwo Xi Stem Cell Applied Technology Co., Ltd.. Status: unknown.
02
Drugs
GXHPC1
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04088058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088058.